India emerging as key centre for clinical trials for paediatric cancer drugs pharmabiz.com It is the Monoclonal antibodies(MABs) like Rituximab, oral targeted therapy like Imatinib and other newer drugs which are being used in clinical trials to improve the survival and quality of life. Both multinational and Indian pharma majors are engaged ... |
